Navigation Links
New PrEP Trial Results Among Injecting Drug Users Underscore That PrEP Works When Taken Consistently
Date:6/12/2013

need to offer these services without criminalizing, stigmatizing or infringing on the rights of those who need them," Warren said. "However, this is the first trial to provide evidence for a prevention option that could protect against HIV infection through both sexual contact and injecting drug use—and this is an exciting finding that must be followed up. PrEP could be a powerful additional tool for some people who inject drugs," Warren added.

CDC's new interim guidelines also released Wednesday include important guidance for how PrEP can best be used to help people who inject drugs protect themselves. Consolidated US Public Health Service Guidelines on PrEP use for all risk groups, which will include more detailed guidance on PrEP use for injecting drug users, are expected to be released later this year.

"We commend the CDC for acting quickly to put these interim guidelines in place to help individuals and their health care providers make informed decisions about PrEP use in the context of comprehensive HIV prevention. PrEP is not a silver bullet or a simple solution, but it is an option that can be life-saving for some individuals," Warren added.

"PrEP using tenofovir-based drugs is a niche product that cannot and will not replace other options that are part of combination prevention. Yet it is an intervention with the real possibility of preventing infections, especially where other prevention options aren't enough," Warren said.

"Now, policy makers, regulators, advocates, WHO, UNAIDS and Gilead Sciences—the manufacturer of both TDF and TDF/FTC—must work together to determine how best to move forward to ensure that PrEP is included where appropriate in comprehensive harm reduction programs for people who inject drugs. PrEP must complement, not replace, harm reduction programs everywhere, and especially in countries and communities with significant HIV epidemics driven by injecting drugs," Warren added.

"AVAC
'/>"/>

SOURCE AVAC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
2. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
3. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
4. SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
5. AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management
6. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
7. Inspiro Medical Ltd. Completes a Successful First Clinical Trial in Asthmatic Children
8. Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials
9. TransCelerate BioPharma Inc. Reveals Collaborative Methodology for Risk-Based Monitoring of Clinical Trials
10. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
11. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015 Harwood Feffer ... the board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" ... the board has breached its fiduciary duties to shareholders. ... a press release announcing results from its first Phase ... press release disclosed that in the trial, Rhopressa failed ...
(Date:4/27/2015)... Research and Markets ( ... "Endoscopy Global Market - Forecast to 2020" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The global endoscopy market ... 2019 growing at around 7.0% CAGR from 2014 ... growth are aging population, increase in cancer, diabetes, ...
(Date:4/27/2015)... , April 27, 2015 Vermillion, ... on gynecologic disease, announced today it will ... the market close on Monday, May 11, ... and webcast at 4:30pm Eastern.Conference Call & ... Eastern/1:30pm Pacific Domestic: , 888-556-4997International: , 719-457-2628Conference ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 3
(Date:4/27/2015)... 2015 The Doctors on Liens ... of personal injury attorneys with the best doctors working on ... steady growth throughout their history and that trend continues with ... and his team in the Tujunga / Sunland ... massage therapist, patients can find comprehensive care and detailed documentation ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 TayganPoint ... is proud to announce their sponsorship of Girls ... Counties. Girls on the Run is a ... through eighth grade. The program is delivered through ... uplifting workouts aimed to develop the whole girl ...
(Date:4/27/2015)... Ticket Down is a reputable source for ... Music Theatre and the Isleta Amphitheater. , ... area can celebrate because their favorite performer will be ... will be performing alongside legendary performers, Huey Lewis and ... the summer and fall months of 2015 are in ...
(Date:4/27/2015)... April 27, 2015 The Mount Sinai ... seamless referral process for the Health System’s care providers. ... failure or diabetes, for instance, may have more than ... coordinate with many other care providers. With medical practices ... thousands of patients each year, the need for an ...
(Date:4/27/2015)... Scooter Direct is now offering Pride ... price of only $929.00, marked down from the MSRP ... is known for offering quality mobility solutions to its ... wheel chairs, lift chairs, and their accessories at unbeatable ... of Go Go Traveller Elite, a senior store manager ...
Breaking Medicine News(10 mins):Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:TayganPoint Consulting Group Announces Sponsorship of Girls on the Run 2Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Mount Sinai Launches System for Faster Referrals 2Health News:Mount Sinai Launches System for Faster Referrals 3Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3
... 31 XStor Medical Systems, a,privately held ... Imaging,Platform for advanced clinical applications and collaborative ... that facilitate participating,hospitals, clinics, and healthcare systems ... physician groups, and patients. The,XStor Imaging Platform ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... pharmaceuticals, today announced that its subsidiary, Watson Laboratories, ... Food and Drug Administration to market its over-the-counter ... the 2 mg and 4 mg strengths.Nicotine Polacrilex ...
... often take gives them only a temporary fix, with tumors ... researchers at Johns Hopkins have discovered critical differences in the ... longer respond to this therapy. The findings, reported in the ... to a way to track disease progression, as well as ...
... BEIJING, Dec. 31 /PRNewswire-Asia-FirstCall/ -- China Medical ... ), a leading China-based medical device,company that ... today announced that the Company has completed ... Focused Ultrasound tumor therapy system,business (the "HIFU ...
... Medical Innovations, Inc. (Amex: IMA ), a ... solutions, announced today that it will attend the upcoming ... 15, 2009 at the Westin St. Francis Hotel in ... Jon Russell, Vice President, Finance, will attend. Mr. ...
... Cisplatin and Oxaliplatin Ototoxicity , More cisplatin enters ... The difference may explain why cisplatin treatment in humans ... , The amount of cisplatin a patient can tolerate ... drug, referred to as ototoxicity. Oxaliplatin is not frequently ...
Cached Medicine News:Health News:XStor Medical Systems Announces the Release of its Imaging Platform for Connectivity Between Healthcare Enterprises 2Health News:Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum 2Health News:Why prostate cancer patients fail hormone deprivation therapy 2Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 2Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 3Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 4Health News:China Medical Technologies Announces the Completion of the Sale of its HIFU Business 5Health News:Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009 2Health News:Also in the Dec. 30 JNCI 2Health News:Also in the Dec. 30 JNCI 3
Micro-mini fiber optic light....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
International version of the Twin Beam, it is BSI-, IEC-, CE- approved....
Cold light source single outlet....
Medicine Products: